DEAFinal Rule
Definition of Cannabimimetic Agents and Assignment of an Administration Controlled Substances Code Number for all Cannabimimetic Agents
HealthcareOther
Ad Space (leaderboard)
Summary
The DEA is creating an official definition and classification system for cannabimimetic agents—chemicals that mimic the effects of cannabis but aren't technically cannabis itself. This rule aims to close loopholes that allow manufacturers to sell cannabis-like products legally by using synthetic or modified versions of the drug.
Key Points
- 1The DEA is defining what counts as a 'cannabimimetic agent' so companies can't sell cannabis look-alikes by claiming they're different substances
- 2All cannabimimetic agents will receive an official DEA controlled substance code, making them illegal to sell or possess without proper authorization
- 3This regulation targets synthetic cannabinoids and other lab-made chemicals designed to produce similar effects to traditional cannabis
- 4Companies currently selling these products will need to stop or face federal penalties for distributing controlled substances
- 5The rule applies nationwide and affects both manufacturers and retailers of these products
Impact Assessment
If you are a manufacturer of synthetic cannabinoid products, this means your current products may be reclassified as controlled substances, requiring reformulation, destruction of inventory, or discontinuation of sales.
Impact Level
Significant
Geographic Scope
National
Compliance Cost
Significant
Who is Affected
ManufacturersSmall BusinessesConsumersImporters/Exporters
Key Dates
Published
January 20, 2026
Regulatory Connections
Authorized By
Amends CFR Sections
21 CFR Part 1308
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
Ad Space (rectangle)